{
    "2018-06-14": [
        [
            {
                "time": "2023-10-01",
                "original_text": "策略点评: AH股溢价指数处于低位, 入摩后北上资金持续加仓",
                "features": {
                    "keywords": [
                        "AH股溢价指数",
                        "北上资金",
                        "加仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "华通医药募资加码高毛利制药业务",
                "features": {
                    "keywords": [
                        "华通医药",
                        "募资",
                        "高毛利",
                        "制药业务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "收评：沪股通净流入19.3亿 深股通净流入9.93亿",
                "features": {
                    "keywords": [
                        "沪股通",
                        "深股通",
                        "净流入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "[中性评级] 医药生物行业周报：关注政策导向 把握结构性机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "政策导向",
                        "结构性机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药行业投资策略报告：医保支出结构调整支持创新药爆发",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医保支出",
                        "创新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "小规模医药转债——华通转债上市定价分析",
                "features": {
                    "keywords": [
                        "医药转债",
                        "华通转债",
                        "上市定价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药生物行业: 关注优先审评受益标的+商业板块",
                "features": {
                    "keywords": [
                        "医药生物",
                        "优先审评",
                        "商业板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}